Cargando…
CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS?
Chemical leukoderma denotes an acquired hypopigmentation caused by repeated exposure to specific chemical compounds simulating clinically idiopathic vitiligo. The ailment has been increasing in developing countries like India in recent years. Etiologically, a lot of chemicals, especially phenolic gr...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965912/ https://www.ncbi.nlm.nih.gov/pubmed/21063518 http://dx.doi.org/10.4103/0019-5154.70680 |
_version_ | 1782189557842706432 |
---|---|
author | Ghosh, Sanjay |
author_facet | Ghosh, Sanjay |
author_sort | Ghosh, Sanjay |
collection | PubMed |
description | Chemical leukoderma denotes an acquired hypopigmentation caused by repeated exposure to specific chemical compounds simulating clinically idiopathic vitiligo. The ailment has been increasing in developing countries like India in recent years. Etiologically, a lot of chemicals, especially phenolic group, have been identified in various countries including India. The term, “chemical leukoderma syndrome” has been described to encompass all the various manifestations of chemical leukoderma. Clinical diagnostic criteria have been proposed to diagnose chemical leukoderma clinically more confidently. |
format | Text |
id | pubmed-2965912 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-29659122010-11-09 CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS? Ghosh, Sanjay Indian J Dermatol IJD Symposium Chemical leukoderma denotes an acquired hypopigmentation caused by repeated exposure to specific chemical compounds simulating clinically idiopathic vitiligo. The ailment has been increasing in developing countries like India in recent years. Etiologically, a lot of chemicals, especially phenolic group, have been identified in various countries including India. The term, “chemical leukoderma syndrome” has been described to encompass all the various manifestations of chemical leukoderma. Clinical diagnostic criteria have been proposed to diagnose chemical leukoderma clinically more confidently. Medknow Publications 2010 /pmc/articles/PMC2965912/ /pubmed/21063518 http://dx.doi.org/10.4103/0019-5154.70680 Text en © Indian Journal of Dermatology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | IJD Symposium Ghosh, Sanjay CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS? |
title | CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS? |
title_full | CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS? |
title_fullStr | CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS? |
title_full_unstemmed | CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS? |
title_short | CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS? |
title_sort | chemical leukoderma: what’s new on etiopathological and clinical aspects? |
topic | IJD Symposium |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965912/ https://www.ncbi.nlm.nih.gov/pubmed/21063518 http://dx.doi.org/10.4103/0019-5154.70680 |
work_keys_str_mv | AT ghoshsanjay chemicalleukodermawhatsnewonetiopathologicalandclinicalaspects |